The evolving market trends reflect increasing adoption of CRT devices globally, positioning the industry for significant growth.

Market Size and Overview The cardiac resynchronization therapy (CRT) market is estimated to be valued at USD 7.94 billion in 2025 and is expected to reach USD 12.42 billion by 2032, growing at a compound annual growth rate (CAGR) of 6.6% from 2025 to 2032.

Investment Scenario Investment in the cardiac resynchronization therapy market has accelerated notably in 2025, with venture capital and private equity showing increased interest in device innovation and digital integration. Recent funding rounds have exceeded USD 300 million across key market players focused on AI-enabled CRT systems and enhanced device longevity.

Strategic mergers and acquisitions have intensified, including cross-border capital allocations to expand manufacturing capabilities in emerging markets. Capital shifts prioritize research and development to address market challenges such as device cost and patient adherence, underpinning sustainable business growth and enhanced market share.

‣ Cardiac Resynchronization Therapy Market: https://www.coherentmi.com/industry-reports/cardiac-resynchronization-therapy-market